Telix Pharmaceuticals Ltd TLX
- 177Lu-DOTA-girentuximab — Clear Cell Renal Cell Carcinoma Phase 3
- TLX252-Tx — Kidney Cancer Preclinical
- Zircaix — Clear Cell Renal Cell Carcinoma Phase 3
CAIX (1 companies · 3 programs)
Companies with an active program directed at CAIX.